1.
The Relationship between the Expression of Yrokinase-type Plasminogen Activator Receptor,and the Infiltration and Metastasis of Gastric Cancer
尿激酶型纤溶酶原激活物受体表达与胃癌浸润和转移过程的关系
2.
Plasma Concentrations Changes and Significance of Plasminogen Activator, Plasminogen Activator Receptor and Plasminogen Activator Inhibitor-1 in Chronic Glomerulonephritis and the Intervenient Research on Them;
慢性肾小球肾炎血浆纤溶酶原激活物及其受体和纤溶酶原激活物抑制剂的变化与干预研究
3.
Clinical Significance of Measurement of Plasma Urokinase Type Plasminogen Activator and its Receptor in Cancer Patients
癌症患者尿激酶型纤溶酶原激活物及其受体检测的临床意义
4.
Expression of urokinase-type plasminogen activator and its receptor protein in synovial tissues from osteoarthritis
骨关节炎滑膜中尿激酶型纤溶酶原激活物及其受体蛋白的表达
5.
Detection and clinical significance of plasma urokinase-type plasminogen activator and its soluble receptor in multiple myeloma patients;
多发性骨髓瘤患者血浆尿激酶型纤溶酶原激活物及其可溶性受体的检测
6.
Clinical Study of the Expression of Tissue Factor and Urokinase Plasminogen Activator Receptor in Breast Cancer
组织因子、尿激酶型纤溶酶原激活剂受体在乳腺癌中的表达
7.
Significance of Urokinase-type Plasminogen Activator and Urokinase-type Plasminogen Activator Receptor in Synovial Fluid of Patients with Temporomandibular Disorders;
颞下颌关节紊乱病关节液中尿激酶型纤溶酶原激活物及其受体的检测
8.
The Relationship of LN-R and uPA in Invasive Ductal Breast Cancer
层粘连蛋白受体、尿激酶型纤溶酶原激活物在乳腺浸润性导管癌中的表达及其相关性
9.
Comparison of Recombinant Tissue Plasminogen Activator, Urokinase and Defibrase in Vitro Simulation of Thrombolytic Test
重组织型纤溶酶原激活剂、尿激酶和降纤酶体外溶栓效果比较
10.
recombinant human plasminogen
重组体人纤溶酶原激活质
11.
The relation of plasma plasminogen activator inhibitor activity and coronary heart disease
纤溶酶原激活抑制物活性与冠心病发病关系
12.
Relationship between plasminogen activator inhibitor 1 and neuroblastoma
纤溶酶原激活物抑制物1与神经母细胞瘤
13.
Preliminary Study on DNA Family Shuffling of Tissue-type Plasminogen Activator Genes;
组织型纤溶酶原激活物DNA改组的探索研究
14.
Plasminogen Activator Inhibitor-1 and Cardiovascular Diseases
纤溶酶原激活物抑制剂-1与心血管疾病
15.
Inhibitory effect of green tea polyphenols on plasminogen activator inhibitor-1 expression
绿茶多酚对纤溶酶原激活物抑制剂-1表达影响
16.
DETERMINATION OF THE PLASMINOGEN ACTIVATOR IN THE TONSIL OF CHRONIC TONSILLITIS
慢性扁桃体炎组织中的纤溶酶原激活剂测定
17.
Study on the Transcriptional Regulation of Urokinase Plasminogen Activator in Human Lung Cancer;
尿激酶型纤溶酶原激活物在人肺癌细胞中表达调控的研究
18.
The Experiment Research That the uPA to Suffer from the Relativity with the Arthritis Disease;
尿激酶型纤溶酶原激活物（uPA）与关节炎性疾患相关性的实验研究